Macesková B
Ustav aplikované farmacie Farmaceutické fakulty Veterinární a farmaceutické univerzity, Brno.
Ceska Slov Farm. 2002 Nov;51(6):292-6.
Knowledge of patients about oral single-component OTC preparations containing ibuprofen, bought for their own use, was evaluated in relation to the manner of the process of communication between the pharmacist (laboratory assistant)--patient during the supply at the pharmacy. The answers of respondents were processed separately for the group of those who bought the preparation for the first time and those who had already used it for self-medication. The knowledge of contraindications and undesirable effects (judged separately) was found to be higher than 50% in both groups of respondents. Nevertheless, the patients who use the preparation repeatedly state simultaneous ignorance of undesirable effects and contraindications only in 32.2%, in contrast to the new users (60.0%). The patients who know neither contraindications nor undesirable effects of the preparation which they buy nevertheless think that they have enough information so that their self-medication can be safe (88.9% of patients using the preparation repeatedly and 80.0% of new users). Approximately a quarter of respondents in both groups under evaluation state that during the supply in the pharmacy they were not given any piece of information. Patients are passive when buying an OTC preparation and nearly 40% of them do not use the opportunity to ask for pertinent information themselves. Nearly 85% of respondents from both groups consider information gained from the pharmacy to be sufficient. When supplying an OTC preparation, in 45% of cases pharmacists (laboratory assistants) do not inquire whether the patient have already used the preparation, or whether he or she knows anything about it. The standard of counselling on self-medication in the Czech Republic should thus become more effective.
针对患者购买自用的含布洛芬的口服单成分非处方药制剂，就药剂师（实验室助理）与患者在药房配药时的沟通方式进行了相关知识评估。对首次购买该制剂的人群和已将其用于自我药疗的人群分别处理了受访者的回答。两组受访者对禁忌和不良反应（分别判断）的知晓率均高于50%。然而，反复使用该制剂的患者中，同时表示对不良反应和禁忌一无所知的仅占32.2%，而新使用者中这一比例为60.0%。那些对所购买制剂的禁忌和不良反应都一无所知的患者却认为他们已获得足够信息，足以确保自我药疗安全（反复使用该制剂的患者中有88.9%，新使用者中有80.0%）。在接受评估的两组中，约四分之一的受访者表示在药房配药时未得到任何信息。患者在购买非处方药制剂时很被动，近40%的患者没有自行询问相关信息的机会。两组中近85%的受访者认为从药房获得的信息足够。在配给非处方药制剂时，45%的情况下药剂师（实验室助理）没有询问患者是否已使用过该制剂，或者是否了解该制剂。因此，捷克共和国自我药疗咨询的标准应变得更加有效。
